Metabolism of Selegiline [(-)-Deprenyl)]

E-ISSN： 1875-533x|21|13|1522-1530

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.13, 2014-04, pp. : 1522-1530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Selegiline (Deprenyl) in the Treatment of Parkinson's Disease

By Heinonen E.H.

Drug Safety, Vol. 19, Iss. 1, 1998-07 ,pp. : 11-22

Adis International

Access to resources Recommend Favorite

The Influence of Metabolism on the MAO-B Inhibitory Potency of Selegiline

Current Medicinal Chemistry, Vol. 9, Iss. 1, 2002-01 ,pp. : 47-51

Bentham Science Publishers

Access to resources Recommend Favorite

Response to selegiline (I-deprenyl) in senile dementia of Alzheimer type: relation to disease stage

By Klashka J. Filip V. David I.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 388-388

Elsevier

Access to resources Recommend Favorite

Selegiline (l-Deprenyl) as a Unique Neuroprotective Agent for Chronic Neurodegenerative Disorders- A Lesson from MAO Inhibition

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 4, 2004-12 ,pp. : 255-267

Bentham Science Publishers

Access to resources Recommend Favorite

EFFECTS OF (-)DEPRENYL (SELEGILINE) ON ACETYLCHOLINESTERASE AND NA⁺,K⁺-ATPase ACTIVITIES IN ADULT RAT WHOLE BRAIN

By Antoniades C. Carageorgiou H. Tsakiris S.

Pharmacological Research, Vol. 46, Iss. 2, 2002-08 ,pp. : 165-169

Academic Press

Access to resources Recommend Favorite